Litcius/Paper detail

Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma

Arghya Ray, Yan Song, Ting Du, Dharminder Chauhan, Kenneth C. Anderson

2020Oncogene47 citationsDOIOpen Access PDF

Topics & Concepts

BiologyCTL*Immune systemCancer researchCD8Cytotoxic T cellBone marrowBortezomibMultiple myelomaEnolaseImmunologyImmunohistochemistryIn vitroBiochemistryHistone Deacetylase Inhibitors ResearchMultiple Myeloma Research and TreatmentsPeptidase Inhibition and Analysis
Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma | Litcius